laitimes

Kanghong Pharmaceutical's performance "changed face" Zheng Hong: Overseas trials are disturbed by the epidemic, short-term fluctuations do not change the domestic efficacy

Overseas clinical trials folded, 1.3 billion research and development costs have been adrift, how much impact on Kanghong Pharmaceutical? Is the project expected to restart in the future? Does the company have other projects that can withstand the pressure of operation? Kanghong Pharmaceutical rose 1.15% in early trading and did not appear to be affected by the performance thunderstorm. In the past month, the stock price has been close to the waist, how to view its future market?

Read on